ReportsandReports – Women’s Well being Therapeutics, Evaluation and Market place Forecasts to 2016


Original Source: Women’s Well being Therapeutics Market

Purchase Now: Market Research

Browse all CHI Healthtech Marketplace Investigation Reports

GBI Research’s report, “Women’s Overall health Therapeutics Market to 2016 – Higher Unmet Require will Drive the Uptake of Novel Drugs in Menopause and Osteoporosis”, provides in-depth evaluation of unmet demands, drivers and barriers that impact the international women’s health marketplace. The report analyzes the markets for women’s health in the US, the best 5 nations in Europe (the UK, Germany, France, Italy and Spain) and Japan. Remedy usage patterns, sales, costs and volumes are forecast till 2016 for the key geographies as nicely as the leading therapeutic segments. Additional, the report offers competitive benchmarking for the top companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

This report is constructed using data and details sourced from proprietary databases, major and secondary analysis and in-house evaluation by GBI Research’s group of business authorities.


The scope of this report involves:

Annualized market data for the women’s health industry from 2001 to 2009, forecast forward to 2016.
Evaluation of the top therapeutic segments, which includes osteoporosis, hormone therapy for menopause, endometriosis, women’s infertility and polycistic ovarian syndrome.
Analysis of the women’s well being market place in the major geographies of the planet, which include the US, the UK, Germany, France, Italy, Spain and Japan.
Market place characterization of the women’s overall health industry, including marketplace size, annual cost of therapy, sales volume and treatment usage patterns.
Essential drivers and barriers that have a significant impact on the market.
Coverage of pipeline molecules in numerous phases of drug improvement.
Competitive benchmarking of leading businesses. The key organizations studied in this report are Merck, Pfizer, Johnson &amp Johnson, Teva Pharmaceuticals and Bayer-Schering Pharma.
Crucial M&ampA activities, licensing agreements, that have taken place in 2009 in the international blood issues market place.

Factors to buy

The report will boost your choice generating capability. It will let you to

Align your solution portfolio to the markets with higher growth possible.
Create market-entry and industry expansion techniques by identifying the major therapeutic segments and geographic markets poised for strong development.
Reinforce R&ampD pipelines by identifying new target mechanisms which can produce first-in-class molecules with much more efficiency and much better safety.
Create crucial strategic initiatives by understanding the important concentrate areas of leading companies.
Exploit in-licensing and out-licensing possibilities by identifying products that could fill portfolio gaps.

About Us

ReportsandReports comprises an on the web library of 10,000 reports, in-depth market research studies of more than 5000 micro markets, and 25 industry specific web sites. Our client list boasts practically all effectively-known publishers of such reports across the globe. We as a third-party reseller of industry analysis reports employ a number of advertising and marketing tools, such as press releases, e-mail-marketing and efficient search-engine optimization strategies to drive revenues for our consumers. We also supply 24/7 online and offline help service to our clients.

Speak to:

Ms. Sunita

7557 Rambler road,

Suite 727, Dallas, TX 75231

Tel: +1-888-989-8004